AI/ML Innovations Inc. (CSE:AIML)
Canada
· Delayed Price · Currency is CAD 0.0350
0.00 (0.00%)
Mar 9, 2026, 3:59 PM EST
AI/ML Innovations Revenue
AI/ML Innovations had revenue of 41.69K CAD in the quarter ending October 31, 2025, with 1.66% growth. This brings the company's revenue in the last twelve months to 168.26K, down -49.78% year-over-year. In the fiscal year ending April 30, 2025, AI/ML Innovations had annual revenue of 167.31K, down -72.12%.
Revenue (ttm)
168.26K
Revenue Growth
-49.78%
P/S Ratio
52.83
Revenue / Employee
n/a
Employees
n/a
Market Cap
8.89M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Apr 30, 2025 | 167.31K | -432.83K | -72.12% |
| Apr 30, 2024 | 600.14K | 112.63K | 23.10% |
| Apr 30, 2023 | 487.50K | 422.10K | 645.32% |
| Apr 30, 2022 | 65.41K | - | - |
| Apr 30, 2021 | - | - | - |
| Apr 30, 2020 | Pro | Pro | Pro |
| Apr 30, 2019 | Pro | Pro | Pro |
| Apr 30, 2018 | Pro | Pro | Pro |
| Apr 30, 2017 | Pro | Pro | Pro |
| Apr 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Comprehensive Healthcare Systems | 5.79M |
| Kovo+ Holdings | 15.06M |
| Seegnal | 1.72M |
| NexgenRx | 17.71M |
| Principal Technologies | 370.42K |
| DIAGNOS | 68.16K |
| nDatalyze | 887.00 |
| CardioComm Solutions | 386.54K |